These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10082528)

  • 1. The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism.
    Sevilla L; Aperlo C; Dulic V; Chambard JC; Boutonnet C; Pasquier O; Pognonec P; Boulukos KE
    Mol Cell Biol; 1999 Apr; 19(4):2624-34. PubMed ID: 10082528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1.
    Sevilla L; Zaldumbide A; Carlotti F; Dayem MA; Pognonec P; Boulukos KE
    J Biol Chem; 2001 May; 276(21):17800-7. PubMed ID: 11278399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive c-ets2 expression in M1D+ myeloblast leukemic cells induces their differentiation to macrophages.
    Aperlo C; Pognonec P; Stanley ER; Boulukos KE
    Mol Cell Biol; 1996 Dec; 16(12):6851-8. PubMed ID: 8943340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS2 is involved in protein kinase C-activated expression of granulocyte-macrophage colony-stimulating factor in human non-small lung carcinoma cell line, A549.
    Lu Z; Kim KA; Suico MA; Uto A; Seki Y; Shuto T; Isohama Y; Miyata T; Kai H
    Biochem Biophys Res Commun; 2003 Mar; 303(1):190-5. PubMed ID: 12646185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells.
    Sapi E; Flick MB; Rodov S; Kacinski BM
    Cancer Res; 1998 Mar; 58(5):1027-33. PubMed ID: 9500466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.
    Smith JL; Schaffner AE; Hofmeister JK; Hartman M; Wei G; Forsthoefel D; Hume DA; Ostrowski MC
    Mol Cell Biol; 2000 Nov; 20(21):8026-34. PubMed ID: 11027273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.
    Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Estrov Z
    Blood; 2003 Jul; 102(2):630-7. PubMed ID: 12663443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors.
    Cao X; Littlejohn J; Rodarte C; Zhang L; Martino B; Rascoe P; Hamid K; Jupiter D; Smythe WR
    Am J Pathol; 2009 Nov; 175(5):2207-16. PubMed ID: 19834061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.
    Carbone GM; Napoli S; Valentini A; Cavalli F; Watson DK; Catapano CV
    Nucleic Acids Res; 2004; 32(14):4358-67. PubMed ID: 15314206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels.
    Hundal RS; Gómez-Muñoz A; Kong JY; Salh BS; Marotta A; Duronio V; Steinbrecher UP
    J Biol Chem; 2003 Jul; 278(27):24399-408. PubMed ID: 12750385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
    Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
    Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5.
    Dibbert B; Daigle I; Braun D; Schranz C; Weber M; Blaser K; Zangemeister-Wittke U; Akbar AN; Simon HU
    Blood; 1998 Aug; 92(3):778-83. PubMed ID: 9680344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
    Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
    Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter.
    Mullick J; Anandatheerthavarada HK; Amuthan G; Bhagwat SV; Biswas G; Camasamudram V; Bhat NK; Reddy SE; Rao V; Avadhani NG
    J Biol Chem; 2001 May; 276(21):18007-17. PubMed ID: 11279115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.
    Carbone GM; McGuffie EM; Collier A; Catapano CV
    Nucleic Acids Res; 2003 Feb; 31(3):833-43. PubMed ID: 12560478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
    Zhang Q; Badell IR; Schwarz EM; Boulukos KE; Yao Z; Boyce BF; Xing L
    Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes.
    Zaldumbide A; Carlotti F; Pognonec P; Boulukos KE
    J Immunol; 2002 Nov; 169(9):4873-81. PubMed ID: 12391198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
    Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
    J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene.
    Wu H; Moulton K; Horvai A; Parik S; Glass CK
    Mol Cell Biol; 1994 Mar; 14(3):2129-39. PubMed ID: 8114743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.